Skip to main content

First PPI Bellwether Trial Scheduling Order Submitted

First PPI Bellwether Trial Scheduling Order Submitted

First PPI Bellwether Trial Scheduling Order Submitted

Introduction

On June 8, 2018, plaintiffs and defendants in the federal litigation over kidney injuries linked to Proton Pump Inhibitors (PPIs) submitted proposals to the Court for the first bellwether scheduling order and trial date. After an initial disagreement, both the parties agreed upon May 2020 as the date to begin the first bellwether trial.

The proposed agenda indicates the parties will review with Judge Checchi a tolling agreement, updates on plaintiff and defendant fact sheets, schedules for depositions, discovery limits and other issues.

More than 4,500 lawsuits against popular heartburn drugs Nexium, Protonix, Prevacid are pending in the federal court alleging the manufacturers failed to warn about the potential risk of chronic kidney disorders.

Similar cases have been centralized as a part of multidistrict litigation (MDL No. 2789; In Re: Proton-Pump Inhibitor Products Liability Litigation [No. II]) in the District of New Jersey before Judge Claire C. Cecchi for coordinated discovery and pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!